The concept of engineering aging represents a groundbreaking shift in how we address the challenges of human longevity. Rather than perceiving aging as an inevitable decline, researchers and innovators like Artem Trotsyuk are exploring ways to intervene at the genetic and cellular levels to extend healthspan and lifespan. Artem Trotsyuk's unique experience as a researcher at Stanford Genetics, an investor with LongeVC, and a builder in biotech startups allows him to view the longevity field from multiple angles. This multidisciplinary approach is vital because longevity science is not only about biology but also about integrating AI technology to accelerate discoveries and develop personalized therapies. One promising area is the use of AI-driven algorithms to analyze vast biological datasets, which helps identify biomarkers of aging and potential targets for intervention. Unlike traditional drug discovery, AI can rapidly predict how combinations of molecules may influence cellular aging processes, enabling more efficient development of therapies. Moreover, startups focusing on healthspan — the period of life spent in good health — are tackling age-associated diseases, ranging from neurodegenerative conditions to metabolic disorders, aiming to compress morbidity into a shorter timeframe. These interventions may ultimately transform how society manages aging populations, reducing healthcare burdens while enhancing quality of life. Beyond scientific advances, the intersection of AI and longevity raises ethical and societal questions. If aging can be engineered or significantly slowed down, access and equity issues become critical. Ensuring that these innovations benefit diverse populations will be essential for their sustainable integration. From personal experience, following developments shared by experts like Artem Trotsyuk on platforms such as Sparknify highlights the excitement and complexity in this field. Watching episodes where key figures share their perspectives helps demystify the science while underscoring how closely investment, research, and technology building intertwine in pushing the frontiers of human health. In summary, the future of aging engineering is a thrilling blend of genetics, AI, and innovative biotech ventures. As we learn to decode and modulate the biological mechanisms of aging, a new era of extended, healthier human life is increasingly within reach.